202 Thacker D, Patel A, Dodds K, et al Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation Ann Thorac Surg 2010;89(3):837–842 203 John AS, Driscoll DJ, Warnes CA, Phillips SD, Cetta F The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation Ann Thorac Surg 2011;92(4):1451–1456 204 Friedland-Little JM, Gajarski RJ, Schumacher KR Dopamine as a potential rescue therapy for refractory protein-losing enteropathy in Fontanpalliated patients Pediatr Transplant 2017;21(4) 205 Ryerson L, Goldberg C, Rosenthal A, Armstrong A Usefulness of heparin therapy in proteinlosing enteropathy associated with single ventricle palliation Am J Cardiol 2008;101(2):248–251 206 Saiki H, Kurishima C, Masutani S, Senzaki H Cerebral circulation in patients with Fontan circulation: assessment by carotid arterial wave intensity and stiffness Ann Thorac Surg 2014;97(4):1394–1399 207 Sarkola T, Jaeggi E, Slorach C, et al Assessment of vascular remodeling after the Fontan procedure using a novel very high resolution ultrasound method: arterial wall thinning and venous thickening in late follow-up Heart Vessels 2013;28(1):66–75 208 Tomkiewicz-Pajak L, Dziedzic-Oleksy H, Pajak J, et al Arterial stiffness in adult patients after Fontan procedure Cardiovasc Ultrasound 2014;12:15 209 Valente AM, Bhatt AB, Cook S, et al The CALF (Congenital Heart Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study J Am Coll Cardiol 2010;56(2):144–150 210 WHOQOL Group The World Health Organization Quality of Life Assessment (WHOQOL): position paper from the World Health Organization Soc Sci Med 1995;41:1403–1409 211 Atz AM, Zak V, Mahony L, et al Survival data and predictors of functional outcome an average of 15years after the Fontan procedure: the Pediatric Heart Network Fontan cohort Congenit Heart Dis 2015;10(1):E30–E42 212 McCrindle BW, Zak V, Pemberton VL, et al Functional health status in children and adolescents after Fontan: comparison of generic and disease-specific assessments Cardiol Young 2014;24(3):469–477 213 d'Udekem Y, Cheung MM, Setyapranata S, et al How good is a good Fontan? Quality of life and exercise capacity of Fontans without arrhythmias Ann Thorac Surg 2009;88(6):1961–1969 214 Kukreja M, Bryant AS, Cleveland DC, et al Health-related quality of life in adult survivors after the Fontan operation Semin Thorac Cardiovasc Surg 2015;27(3):299–306 215 Fteropoulli T, Stygall J, Cullen S, Deanfield J, Newman S Quality of life of adult congenital heart disease patients: a systematic review of the literature Cardiol Young 2013;23(4):473–485 216 Latal B, Helfricht S, Fischer JE, Bauersfeld U, Landolt MA Psychological adjustment and quality of life in children and adolescents following open-heart surgery for congenital heart disease: a systematic review BMC Pediatr 2009;9:6 217 Bertoletti J, Marx GC, Hattge Junior SP, Pellanda LC Quality of life and congenital heart disease in childhood and adolescence Arq Bras Cardiol 2014;102(2):192–198 218 Casey FA, Stewart M, McCusker CG, et al Examination of the physical and psychosocial determinants of health behaviour in 4-5-year-old children with congenital cardiac disease Cardiol ... Survival data and predictors of functional outcome an average of 15years after the Fontan procedure: the Pediatric Heart Network Fontan cohort Congenit Heart Dis 2015;10(1):E30–E42 212 McCrindle BW, Zak V, Pemberton VL, et al